Suzhou Zelgen Biopharmaceuticals Co Ltd Free Cash Flow Generation Index

Latest as of September 2025: -96.08x

Suzhou Zelgen Biopharmaceuticals Co Ltd free cash flow generation index. Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a Free Cash Flow Generation Index of -96.08x as of September 2025. Free cash flow of CN¥-52.24 Million represents -96% of operating cash flow (CN¥543.69K).

FCF Generation Index

-96.08x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-52.24 Million
CNY

Operating Cash Flow

CN¥543.69K
CNY

Capital Expenditures

CN¥52.78 Million
CNY

Free Cash Flow Generation Index of Suzhou Zelgen Biopharmaceuticals Co Ltd (2024–2024)

Free cash flow generation index of Suzhou Zelgen Biopharmaceuticals Co Ltd from 2024 to 2024. Historical FCF Generation Index trend for Suzhou Zelgen Biopharmaceuticals Co Ltd across 1 annual periods. See financial flexibility index of Suzhou Zelgen Biopharmaceuticals Co Ltd to measure the company's free cash flow as a share of total liabilities.

Suzhou Zelgen Biopharmaceuticals Co Ltd Free Cash Flow Generation Index by Year (2024–2024)

Suzhou Zelgen Biopharmaceuticals Co Ltd free cash flow generation index by year from 2024 to 2024. Year-by-year Free Cash Flow Generation Index for Suzhou Zelgen Biopharmaceuticals Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Suzhou Zelgen Biopharmaceuticals Co Ltd.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 -1.50x CN¥-57.49 Million CN¥38.20 Million CN¥95.69 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).